The estimated Net Worth of Ian C Read is at least $66.8 Миллион dollars as of 21 March 2022. Mr. Read owns over 166 units of Kimberly-Clark stock worth over $2,075,970 and over the last 17 years he sold KMB stock worth over $64,431,750. In addition, he makes $320,000 as Lead Independent Director at Kimberly-Clark.
Ian has made over 23 trades of the Kimberly-Clark stock since 2007, according to the Form 4 filled with the SEC. Most recently he exercised 166 units of KMB stock worth $23,771 on 21 March 2022.
The largest trade he's ever made was exercising 1,100,201 units of Kimberly-Clark stock on 2 November 2018 worth over $29,309,355. On average, Ian trades about 41,811 units every 28 days since 2007. As of 21 March 2022 he still owns at least 14,497 units of Kimberly-Clark stock.
You can see the complete history of Mr. Read stock trades at the bottom of the page.
Ian C. Read serves as Lead Independent Director of the Company. Mr. Read served as Executive Chairman of Pfizer, Inc., a drug manufacturer, from January 2019 to December 2019. Prior to that, he served as Chairman of the Board and Chief Executive Officer since 2011 and President and Chief Executive Officer since 2010. Mr. Read joined Pfizer in 1978 in its financial organization. He worked in Latin America through 1995, holding positions of increasing responsibility, and was appointed President of the Pfizer International Pharmaceuticals Group, Latin America/Canada in 1996. In 2000, Mr. Read was named Executive Vice President of Europe/Canada and was named a corporate Vice President in 2001. In 2006, he was named Senior Vice President of Pfizer, as well as Group President of its Worldwide Biopharmaceutical Businesses. Other public company boards served on since 2015: Pfizer, Inc. (through December 2019) Experience attributes: Mr. Read satisfies the financial literacy requirements of the NYSE and has a background in finance, has leadership experience as a chief executive officer, provides diversity of background and viewpoint, has international experience, and has marketing, compensation, governance and public company board experience.
As the Lead Independent Director of Kimberly-Clark, the total compensation of Ian Read at Kimberly-Clark is $320,000. There are 9 executives at Kimberly-Clark getting paid more, with Michael Hsu having the highest compensation of $12,028,100.
Ian Read is 67, he's been the Lead Independent Director of Kimberly-Clark since 2017. There are 3 older and 26 younger executives at Kimberly-Clark. The oldest executive at Kimberly-Clark Corp. is Abelardo Bru, 71, who is the Independent Director.
Ian's mailing address filed with the SEC is 1000 MYLAN BOULEVARD, , CANONSBURG, PA, 15317.
Over the last 22 years, insiders at Kimberly-Clark have traded over $159,938,823 worth of Kimberly-Clark stock and bought 48,802 units worth $3,913,665 . The most active insiders traders include Ian C Read, Thomas J Falk и Michael D White. On average, Kimberly-Clark executives and independent directors trade stock every 19 days with the average trade being worth of $2,895,934. The most recent stock trade was executed by Zackery A Hicks on 29 July 2024, trading 5,171 units of KMB stock currently worth $740,487.
kimberly-clark makes the essentials for a better life with well-known brands that matter every day – at home, school, work and on the go. throughout our 144 years, we have challenged conventional wisdom to innovate products that better meet the needs of consumers. we have created new categories with top brands like kleenex®, and redefined categories with huggies® and u by kotex®. while growing our $18+ billion global business, we help build careers through collaborative teams that push boundaries and engaging experiences and endless opportunities to work with some of the world’s most recognized brands. our 43,000 employees are changing the world for the better, too, generously giving back to communities and causes around the globe. if innovative thinking and a passion to win inspire you, come unleash your power at kimberly-clark.
Kimberly-Clark executives and other stock owners filed with the SEC include: